0000891293-15-000014.txt : 20150324 0000891293-15-000014.hdr.sgml : 20150324 20150324185644 ACCESSION NUMBER: 0000891293-15-000014 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150321 FILED AS OF DATE: 20150324 DATE AS OF CHANGE: 20150324 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CTI BIOPHARMA CORP CENTRAL INDEX KEY: 0000891293 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911533912 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3101 WESTERN AVENUE STREET 2: SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 2062827100 MAIL ADDRESS: STREET 1: 3101 WESTERN AVENUE STREET 2: SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98121 FORMER COMPANY: FORMER CONFORMED NAME: CELL THERAPEUTICS INC DATE OF NAME CHANGE: 19960321 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Plunkett Matthew CENTRAL INDEX KEY: 0001557551 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12465 FILM NUMBER: 15722934 MAIL ADDRESS: STREET 1: 3101 WESTERN AVENUE, SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98121 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2015-03-21 0 0000891293 CTI BIOPHARMA CORP CTIC 0001557551 Plunkett Matthew 3101 WESTERN AVENUE, SUITE 600 SEATTLE WA 98121 0 1 0 0 EVP, Corporate Development Common Stock 2015-03-21 4 F 0 59784 1.935 D 787439 D Common Stock 2015-03-23 4 S 0 1600 1.95 D 785839 D Common Stock 2015-03-23 4 S 0 7903 1.955 D 777936 D Common Stock 2015-03-23 4 S 0 28197 1.96 D 749739 D Common Stock 2015-03-23 4 S 0 11700 1.965 D 738039 D Common Stock 2015-03-23 4 S 0 5184 1.97 D 732855 D Common Stock 2015-03-23 4 S 0 2216 1.975 D 730639 D Common Stock 2015-03-23 4 S 0 2330 1.98 D 728309 D Represents shares withheld by CTIC to satisfy tax withholding obligations on the vesting of restricted stock. The sale was effected pursuant to a rule 10b5-1 trading plan. By: Louis A. Bianco, Attorney-in-fact For: Matthew Plunkett 2015-03-24